Journal
CURRENT OPINION IN IMMUNOLOGY
Volume 21, Issue 3, Pages 359-363Publisher
CURRENT BIOLOGY LTD
DOI: 10.1016/j.coi.2009.05.001
Keywords
-
Categories
Ask authors/readers for more resources
Alzheimer disease (AD) is the most common neurodegenerative disorder. Currently available therapies may slow cognitive decline but do not alter underlying disease processes. Considerable effort over the last decade has been directed toward the development of vaccines for AD; these have been primarily directed against the A beta peptide, a component of senile plaques. More recently, alternative approaches have begun to target the microtubule binding protein tau, a component of neurofibrillary tangles. Immunotherapies based upon oligomeric species of tau represent a promising new approach for AD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available